Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

CAPR SPEC

(CPSR)
Delayed Nyse  -  04:00 2022-09-30 pm EDT
1.080 USD   -.--%
04/22Capstar Special Purpose Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
01/20Capr Spec27 : Gelesis®, the Maker of Plenity® for Weight Management, Will Debut as a Publicly Traded Company Following the Closing of its Business Combination with Capstar - Form 8-K
PU
01/14Health Care Stocks Unable to Pare All of Their Earlier Decline by Friday Close
MT
SummaryQuotesChartsNewsCompanyFinancialsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société CAPR SPEC
01/20Capr Spec27 : Gelesis®, the Maker of Plenity® for Weight Management, Will Debut as a Publi..
PU
01/13Gelesis®, the Maker of Plenity® for Weight Management, Will Debut as a Publicly Traded ..
BU
01/12Capstar Special Purpose Acquisition : Submission of Matters to a Vote of Security Holders ..
PU
01/12Capstar Special Purpose Acquisition : Submission of Matters to a Vote of Security Holders..
AQ
01/10Capstar Special Purpose Acquisition : Other Events (form 8-K)
AQ
01/05Gelesis Adds Inogen Co-Founder and Former CFO Ali Bauerlein to Board of Directors and A..
BU
01/03Capstar Special Purpose Acquisition : Entry into a Material Definitive Agreement, Unregis..
AQ
2021Have Your Cake And Eat It Too : Plenity® Creates Edible Dessert Billboard to Challenge Ove..
BU
2021Capstar Special Purpose Acquisition : Change in Directors or Principal Officers (form 8-K..
AQ
2021Gelesis' FDA-Cleared Weight Management Approach, Plenity®, Now Broadly Available and Le..
BU
2021CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. - 10-K/A - Management's Discussion and Analys..
AQ
2021Gelesis Receives $30 Million Plenity Order from Ro
BU
2021CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINA..
AQ
2021Capstar Special Purpose Acquisition : Non-Reliance on Previous Financials, Audits or Inte..
AQ
2021Capstar Special Purpose Acquisition : Entry into a Material Definitive Agreement, Financi..
AQ
2021Nature's Scientific Reports Features Gelesis' Novel and Foundational Biomimetic Platfor..
BU
2021Two Senior Scientific Leaders at Gelesis Awarded Top Industry Honors
BU
2021Capstar Special Purpose Acquisition : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CO..
AQ
2021Capstar Special Purpose Acquisition : Financial Statements and Exhibits (form 8-K/A)
AQ
2021Capstar Special Purpose Acquisition : Gelesis, a Consumer-Focused Biotherapeutics Company ..
PU
2021Capstar Special Purpose Acquisition : Entry into a Material Definitive Agreement, Unregis..
AQ
2021Capstar Special Purpose Acquisition : Gelesis, a Consumer-Focused Biotherapeutics Company ..
BU
2021Capstar Special Purpose Acquisition : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CO..
AQ
2021Capstar Special Purpose Acquisition : 10-K/A - Management's Discussion and Analysis of Fin..
AQ
2021Capstar Special Purpose Acquisition : Notice of Delisting or Failure to Satisfy a Continu..
AQ
2021Capstar Special Purpose Acquisition : Receives Expected Notice from NYSE Regarding Delaye..
BU
2021Capstar Special Purpose Acquisition : Non-Reliance on Previous Financials, Audits or Inte..
AQ
2021Capstar Special Purpose Acquisition : Management's Discussion and Analysis of Financial Co..
AQ
2020Capstar Special Purpose Acquisition : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CO..
AQ